Skip to main content
HANDOK Inc. logo

HANDOK Inc. — Investor Relations & Filings

Ticker · 002390 ISIN · KR7002390003 KO Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2024-02-06 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 002390

About HANDOK Inc.

https://www.handok.co.kr/en/

Handok Inc. is a total healthcare company that develops, manufactures, and distributes a comprehensive range of healthcare solutions. Its portfolio includes prescription drugs, general medicine, medical devices, and in-vitro diagnostics. The company's core business focuses on therapeutic areas such as diabetes, cardiovascular and musculoskeletal diseases, and psychoneurotic disorders, in addition to human vaccines. Positioning itself as a "Health Innovator," Handok provides products and services aimed at prevention, diagnosis, and health management. The company collaborates with global enterprises and manages the entire value chain from sourcing and development to commercialization.

Recent filings

Filing Released Lang Actions
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Supervisory Service/Korea Exchange. It details the specific terms of stock option grants, including the number of shares, exercise price, grant date, and legal basis under the company's articles of incorporation. This type of disclosure regarding capital structure changes and equity-based compensation is classified as a share issue or capital change announcement.
2024-02-06 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically marked as a '정정신고' (Correction Report). It details changes to previously reported stock option grants, including adjustments to the number of shares and the number of recipients. This type of disclosure regarding stock options and capital-related changes falls under the category of Regulatory Filings (RNS) as it is a specific corporate announcement required by the Korea Exchange/Financial Supervisory Service that does not fit into more specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for new capital issuance).
2024-02-06 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Handok) announcing a significant change in financial structure (revenue or profit/loss change of 30% or more). This is a standard preliminary earnings disclosure required by the Korea Exchange (KRX) before the final audited annual report is filed. It provides key financial highlights and reasons for the change, fitting the definition of an Earnings Release (ER). FY 2023
2024-02-06 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details specific changes to the number of shares and the list of recipients for stock options. In the context of financial filings, announcements regarding stock options, capital changes, or equity-based compensation adjustments that do not fit into specific categories like 'Director's Dealing' or 'Remuneration' are classified as Regulatory Filings (RNS) as they are official corporate disclosures to the exchange.
2024-02-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status of major shareholders and their special related parties, including changes in collateral agreements. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-01-02 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the specific terms, conditions, and recipients of stock options granted by Handok Inc. This type of disclosure regarding capital structure changes and equity-based compensation falls under the category of share issues or capital changes.
2023-12-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.